If You Invested $1,000 In Dogecoin On Jan. 1, 2021, Here’s How Much You’d Have Now
Two years ago, one of the trending topics across social media was Dogecoin (CRYPTO: DOGE), a meme cryptocurrency.
Can Prison Stocks Break The Shackles And Rally Amid Trump’s Potential Arrest This Tuesday?
Prison stocks are underperforming in the current market recovery, with three major publicly-traded ones trading deep in the red in the year to date. This marks a reversal from 2022, when the stocks notched spectacular gains despite the broader market swoon.
Majority Of Dogecoin Holders In Profit, While 67% Of Shiba Inu Owners Are Underwater
Leading blockchain analytics firm IntoTheBlock has reported that Dogecoin (CRYPTO: DOGE) holders are in profit while Shiba Inu (CRYPTO: SHIB) holders are underw
Reviving The Classics: Atari Acquires Berzerk, Frenzy And 10 More Arcade Properties
Atari (OTC: PONGF), the renowned interactive entertainment producer and consumer brand, has announced its acquisition of a dozen retro arcade games, including the classic 80s titles "Berzerk" and "Frenzy."
UBS Offers To Buy Credit Suisse For Up To $1 Billion, But Proposal Seen As Too Low
UBS Group AG (NYSE: UBS) has offered to buy Credit Suisse Group AG (NYSE: CS) for up to $1 billion, according to the Financial Ti
EXCLUSIVE: Ketamine Therapy Provider Nushama Co-Founder On Shifting From A Consciousness Of Blame Into A Space Of Responsibility
In light of the latest news regarding the DEA’s telehealth regulations and the
Benzinga’s ‘Stock Whisper’ Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
Investors are on the hunt for undervalued, underfollowed and emerging stocks when it comes to spotting opportunities. Retail traders have countless methods at their disposal to uncover new information.
Connect Biopharma Announced CBP-201 Atopic Dermatitis China Pivotal Study Met Primary And Secondary Endpoints
Connect Biopharma Holdings Limited (NASDAQ: CNTB) announced that data from Stage 1 of the ongoing pivotal CBP-201 China trial in moderate-to-severe atopic dermatitis (AD) showed rapid relief from symptoms, as early as week one in some cases, and no efficacy plateau at Week 16.
Benzinga Bulls And Bears: Tesla, Amazon, Meta And Shiba Inu Developer Admits To Big Mistake
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.
UBS In Talks To Acquire Credit Suisse, BlackRock Denies Takeover Bid
UBS Group AG (NYSE: UBS) is exploring options to take over all or part of Credit Suisse Group AG (NYSE: CS) but has asked the Swiss government's support to cover future risks if it were to